Multiple Sclerosis Clinical Trials in Seattle, Washington

4 studies are recruiting for multiple sclerosis in Seattle, Washington right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

    This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multiple Sclerosis.

    Stage
    Phase 1
    Ages
    18 to 60
    Site
    Research Site, Seattle, Washington
    Locations
    19 in total
    Run by
    AstraZeneca

    See if you can join NCT07224373 on ClinicalTrials.gov

  2. A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

    This study will have two Phases: Phase 1a and Phase 1b. The goals of this clinical study are to learn more about the study drug KITE-363, by evaluating its safety, tolerability and efficacy in participants with relapsed/refractory autoimmune neurologic diseases. The primary objectives of this study…

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Fred Hutchinson Cancer Center, Seattle, Washington
    Locations
    8 in total
    Run by
    Kite, A Gilead Company

    See if you can join NCT07304154 on ClinicalTrials.gov

  3. Single Arm Trial Identifying Barriers and Facilitators to Mindfulness Practice

    This observational study will examine what emotional, physical, and environmental factors make it easier or harder for people with multiple sclerosis (MS) and chronic pain to practice mindfulness daily while participating in a group-based Mindfulness-Based Cognitive Therapy (MBCT) program.

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Washington, Seattle, Washington
    Run by
    University of Washington

    See if you can join NCT07573241 on ClinicalTrials.gov

  4. Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue

    This randomized controlled factorial trial will examine whether and how relaxation training, behavioral activation, and cognitive therapy improve fatigue and functioning in fatigued adults living with multiple sclerosis.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Multiple Sclerosis Center at UW Medical Center - Northwest, Seattle, Washington
    Run by
    University of Washington

    See if you can join NCT06809192 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.